@OphthTimes Nice talk. You did not reference the paper or state who did it or where it was from. For those interested, it is here: https://t.co/6nRX8h3De2
@BogochIsaac You're missing a lot of patient groups there, including:
1. Substantially increase risk of autoimmune disease post covid https://t.co/eOg7vgfd0R
2. Increased risk of other infections post covid https://t.co/Rr3ATetLHt
3. Cardiovascular presentations (we see CRAO) or other stroke
@lisa_iannattone@ASPphysician ID pages us (ophthalmology) when there is candida in the blood for an eye check. The chance of an eye issue on a routine exam like this is minutely small. ID will still fight for it. I guess we can start to ramp off of this now too since we are at a different place now in 2023.
@lisa_iannattone This makes sense since we have therapeutics for surgical site infections. It will make the surgeon feel more comfortable. We are at a different place now compared to 2020